HMOX1 and chronic myelogenous leukemia, BCR-ABL1 positive: Recently, it has been demonstrated that PI3K/AKT-dependent HO-1 induction drives drug resistance to imatinib in CML [190] as well as to panobinostat in AML [191] by modulating the expression of HDACs.